- Home
- INTS vs FMST Comparison
INTS vs FMST Comparison
Compare INTS & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- FMST
- Stock Information
- Founded
- INTS 2012
- FMST 2005
- Country
- INTS United States
- FMST Canada
- Employees
- INTS N/A
- FMST N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- FMST Other Metals and Minerals
- Sector
- INTS Health Care
- FMST Basic Materials
- Exchange
- INTS Nasdaq
- FMST Nasdaq
- Market Cap
- INTS 8.7M
- FMST 7.1M
- IPO Year
- INTS 2023
- FMST N/A
- Fundamental
- Price
- INTS $0.46
- FMST $4.82
- Analyst Decision
- INTS Strong Buy
- FMST
- Analyst Count
- INTS 3
- FMST 0
- Target Price
- INTS $8.50
- FMST N/A
- AVG Volume (30 Days)
- INTS 1.3M
- FMST 1.5M
- Earning Date
- INTS 05-13-2025
- FMST 01-01-0001
- Dividend Yield
- INTS N/A
- FMST N/A
- EPS Growth
- INTS N/A
- FMST N/A
- EPS
- INTS N/A
- FMST N/A
- Revenue
- INTS N/A
- FMST N/A
- Revenue This Year
- INTS N/A
- FMST N/A
- Revenue Next Year
- INTS N/A
- FMST N/A
- P/E Ratio
- INTS N/A
- FMST N/A
- Revenue Growth
- INTS N/A
- FMST N/A
- 52 Week Low
- INTS $0.29
- FMST $0.55
- 52 Week High
- INTS $5.10
- FMST $5.74
- Technical
- Relative Strength Index (RSI)
- INTS 38.44
- FMST 86.21
- Support Level
- INTS $0.29
- FMST $2.79
- Resistance Level
- INTS $0.63
- FMST $5.74
- Average True Range (ATR)
- INTS 0.09
- FMST 0.68
- MACD
- INTS 0.06
- FMST 0.26
- Stochastic Oscillator
- INTS 50.88
- FMST 95.88
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with significant historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec.